Dublin, July 08, 2019 (GLOBE NEWSWIRE) -- The "Cell-based Assay Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering.
The global cell-based assay market reached a value of US$ 14 Billion in 2018. The market value is further expected to reach more than US$ 23 Billion by 2024, exhibiting a CAGR of 8.6% during 2019-2024.
This report provides a deep insight into the global cell-based assay market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc.
The market is currently being catalysed by a number of factors, this includes rising investments in research and development, adoption of high throughput screening methods, increasing prevalence of various chronic diseases, growth in drug discovery activities, and the various advantages that cell-based assays offer over alternative technologies.
There has been a significant increase in R&D funding by various public and private organisations so as to develop better and safer drugs. Moreover, technological advancements in cell-based assays have enabled researchers to start using this technology for drug discovery and toxicology studies.
Another major factor catalysing the growth of the market is the rising prevalence of lifestyle diseases such as arthritis, diabetes, epilepsy, cancer, cardiovascular diseases, etc. which still have large unmet needs and have led to continuous investments in R&D.
In addition, an increase in the adoption of the cell-based assay techniques for high throughput screening methods like toxicity studies, drug screening, in vitro testing, etc. are further driving this market.
Based on the product type, the market has been segmented as consumables, instruments, services and software. Currently, the consumables segment dominates the market, holding the largest share.
Based on the technology, the market has been segmented as automated handling, flow cytometry, label-free-detection, high-throughput screening, and others.
Based on the application, the market has been segmented as drug discovery, basic research, ADME studies, predictive toxicology and others. Currently, the drug discovery segment dominates the market, holding the largest share.
On the basis of end-user, the market has been segmented as pharmaceutical and biotechnology companies; academic and government institutions; contract research organizations; and others.
Region-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. Amongst these, North America is the leading market, accounting for the majority of the market share.
The competitive landscape of the market has also been examined with some of the key players being Becton Dickinson, Danaher Corporation, Thermo Fisher Scientific, General Electric, Merck KGaA, Perkinelmer, Charles River Laboratories, Lonza Group, Cell Signaling Technology, Promega Corporation, Cisbio Bioassays, Cell Biolabs, Bio-Rad Laboratories, Corning, and F. Hoffmann-La Roche.
Key Questions Answered
2 Scope and Methodology
2.1 Objectives of the Study
2.3 Data Sources
2.4 Market Estimation
2.5 Forecasting Methodology
3 Executive Summary
4.2 Key Industry Trends
5 Global Cell-Based Assay Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Breakup by Product and Services
5.4 Market Breakup by Technology
5.5 Market Breakup by Application
5.6 Market Breakup by End-User
5.7 Market Breakup by Region
5.8 Market Forecast
5.9 SWOT Analysis
5.10 Value Chain Analysis
5.11 Porters Five Forces Analysis
5.11.2 Bargaining Power of Buyers
5.11.3 Bargaining Power of Suppliers
5.11.4 Degree of Competition
5.11.5 Threat of New Entrants
5.11.6 Threat of Substitutes
6 Market Breakup by Product and Services
6.4 Software AG
7 Market Breakup by Technology
7.1 Automated Handling
7.2 Flow Cytometry
7.3 Label-Free Detection
7.4 High-Throughput Screening
8 Market Breakup by Application
8.1 Drug Discovery
8.2 Basic Research
8.3 ADME Studies
8.4 Predictive Toxicology
9 Market Breakup by End-user
9.1 Pharmaceutical & Biotechnology Companies
9.2 Academic & Government Institutions
9.3 Contract Research Organizations
10 Market Breakup by Region
10.1 North America
10.4 Middle East & Africa
10.5 Latin America
11 Competitive Landscape
11.1 Market Structure
11.2 Key Players
11.3 Profiles of Key Players
11.3.1 Becton Dickinson
11.3.2 Danaher Corporation
11.3.3 Thermo Fisher Scientific.
11.3.4 General Electric
11.3.5 Merck KGaA Group
11.3.7 Charles River Laboratories Inc.
11.3.8 Lonza Group Ltd.
11.3.9 Cell Signaling Technology
11.3.10 Promega Corporation
11.3.11 Cisbio Bioassays
11.3.12 Cell Biolabs Inc.
11.3.13 Discoverx Corporation
11.3.14 Bio-Rad Laboratories Inc.
11.3.16 Hoffmann-La Roche Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/einj10
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Biotechnology